Abstract
To identify the economic challenges experienced by individuals living with generalized myasthenia gravis (gMG), a rare autoimmune disorder, and facing social determinants of health (SDOH) barriers.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
